MRM Health NV
MRM Health NV is a clinical-stage biopharmaceutical company focused on developing microbiome-based Live Biotherapeutic Products (LBPs) for chronic inflammatory diseases and immune-oncology. Utilizing its proprietary CORAL® platform, MRM Health designs and manufactures disease-targeted microbial consortia with enhanced efficacy and scalability. The company is advancing its lead program, MH002, into pivotal clinical development for ulcerative colitis and pouchitis, alongside other preclinical programs targeting various inflammatory conditions. Through strategic partnerships, MRM Health aims to expand its portfolio of innovative therapeutics in both human and animal health.
Leadership & Board
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $55M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $55M
- Latest Funding Round
- Series B
- Post-Money Valuation
- ―
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Sep 04, 2025 | Series B | $55.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| ATHOS | Series B |
| Biocodex | Series B |
| BNP Paribas Fortis Private Equity | Series B |
| SFPIM | Series B |
| Ackermans & van Haaren | Series B |
| OMX Europe Venture Fund | Series B |
| Qbic II | Series B |
| VIB | Series B |
Similar Companies
A snapshot of private companies similar to MRM Health NV, helping you discover and navigate related company profiles.
Related News and Analysis
